Search

everythinglearnresearchcommunity

for

Search:↓

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Keratin 10 end domains may increase skin cancer risk by reducing cell death.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

The same genetic mutation in Sjögren-Larsson syndrome can lead to different levels of severity, suggesting other factors influence the symptoms.

JAK inhibitors might help treat alopecia areata.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

JAK inhibitors show promise in treating difficult skin diseases.

JAK inhibitors show promise for treating skin diseases effectively and safely.

A unique gene mutation was found in a family with monilethrix.

A mutation in the KRT71 gene causes a hair disorder by disrupting hair follicle structure and texture.

Keratin mutations cause skin diseases and could lead to new treatments.

Removing both KLK5 and KLK7 proteins can prevent death and skin issues in Netherton syndrome.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

LIPH mutations in Japan cause varying degrees of hair loss and woolly hair.

KIT's role in skin cells is not entirely independent, as other cells can influence its function.

A specific mutation in the K25 gene causes a rare genetic disorder with curly hair at birth and later hair loss, along with dental issues.

A mouse gene mutation increases the risk of skin cancer.

Monilethrix severity varies and may be influenced by other genetic or environmental factors.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

A new gene mutation is linked to monilethrix in the studied family.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

CLEC4D gene variants may increase the risk of alopecia areata in Jordanians.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Different STUB1 gene mutations cause varied symptoms in autosomal recessive ataxias.

Mutations in the desmoplakin gene can cause hair problems and deadly heart disease.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.